Yes, laser treatment can cause hyperpigmentation, and it does so more often than most clinic brochures admit. The mechanism is post-inflammatory hyperpigmentation (PIH): heat and light injury overstimulate melanocytes, which then deposit excess melanin along the treated zone. Reported incidence for pigment-specific lasers ranges from about 2% to 18%, and it climbs above 30% in darker Fitzpatrick types (IV to VI) when fluence and cooling are poorly matched. The effect is usually delayed rather than immediate, appearing 2 to 6 weeks after a session, and it is often reversible within 3 to 6 months if the trigger is removed and sun protection is strict.
How Laser Energy Triggers Melanin Overproduction
Laser hyperpigmentation starts with a physical insult, not a pigment "side effect" in the cosmetic sense. Photons are absorbed by chromophores in the skin, chiefly melanin, hemoglobin, and water. When melanin absorbs the pulse, the melanocyte heats to roughly 60 to 70 degrees Celsius within microseconds, which is the intent in hair removal and pigment clearance. The same heat injures the cell membrane and triggers a stress response.
That stress response is the root of the problem. Damaged keratinocytes release inflammatory mediators, including prostaglandins, interleukin-1, and endothelin-1. Endothelin-1 is the most potent known melanocyte mitogen, and it upregulates tyrosinase, the rate-limiting enzyme in melanin synthesis. In plain terms: the laser does not "spread" pigment; it provokes the skin into making more of it during repair.
Two damage patterns matter. The first is epidermal injury, where the basal layer is disrupted and pigment drops into the dermis, producing a gray-blue tint. The second is dermal heating, where the inflammatory cascade outlasts the visible redness. A third, less obvious route is "paradoxical darkening": pigment-specific lasers such as Q-switched 532 nm can clear part of a lesion while leaving untreated margins that look darker by contrast.
The depth of the chromophore interaction sets the risk. Melanin absorbs across 250 to 1,200 nm, so almost any visible or near-infrared laser can hit it. Hemoglobin absorbs best at 532 and 577 to 595 nm. Water dominates beyond 1,200 nm. This overlap explains why even "non-pigment" devices such as 755 nm alexandrite hair removal can leave a hyperpigmented stripe on the upper lip or jaw.
Quantified Risk by Laser Type and Skin Tone
The table below consolidates published and device-label risk ranges for PIH across common platforms. Figures represent treatment of benign pigment or hair, not oncologic laser use.
| Laser platform | Wavelength | Primary target | Approx. PIH risk, fair skin (types I–III) | Approx. PIH risk, dark skin (types IV–VI) |
|---|---|---|---|---|
| Q-switched Nd:YAG | 1064 nm | Melanin (deep) | 2–6% | 8–20% |
| Q-switched Nd:YAG | 532 nm | Melanin (superficial) | 4–10% | 15–35% |
| Q-switched ruby | 694 nm | Melanin | 5–12% | 20–40% |
| Alexandrite | 755 nm | Melanin, hair | 3–8% | 15–30% |
| Pulsed dye | 595 nm | Hemoglobin | 1–3% | 3–8% |
| Fractional CO2 | 10,600 nm | Water | 2–5% | 8–18% |
| Diode (hair) | 810 nm | Melanin, hair | 1–4% | 6–15% |
Dark skin carries higher risk for two reasons. Higher baseline epidermal melanin competes with the target chromophore, raising the chance of unintended epidermal heating. And darker skin has a more reactive melanocyte population, so the same inflammatory stimulus yields more pigment output. A 2020 review in the Journal of Cosmetic Dermatology noted that PIH after laser in Fitzpatrick IV to VI skin is the single most common reported complication, and that risk increases with each additional pass over the same area.
The Hyperpigmentation Timeline After a Laser Session
The time course is predictable enough to plan around. Immediate redness and swelling are expected and resolve in 1 to 3 days. The pigment change that alarms patients appears later, because tyrosinase upregulation and melanin transfer take time.
| Time after session | What is happening | What you see |
|---|---|---|
| 0–24 hours | Thermal injury, capillary dilation | Erythema, mild edema, warmth |
| 24–72 hours | Inflammatory mediator peak | Redness fading, possible crusting |
| Day 3–10 | Basal layer repair, early melanin shift | Faint brown tint at treated edges |
| Week 2–4 | Tyrosinase activity elevated 2–5x | Visible brown-to-gray patch forming |
| Week 4–6 | Melanin deposition consolidates | Peak darkness, defined borders |
| Week 6–12 | Macrophage clearance begins | Slow lightening, often uneven |
| Month 3–6 | Dermal pigment turnover | Most cases resolve 60–90% |
| Month 6–12 | Residual dermal pigment | Persistent gray-blue tint in a minority |
One number matters more than the rest: about 90% of laser-induced PIH resolves within 6 months with strict photoprotection and no further irritation. The remaining minority carries dermal pigment, which clears far more slowly and sometimes needs a different laser to treat.
Epidermal vs. Dermal Pigment: Why Depth Changes the Outlook
Superficial, epidermal hyperpigmentation sits above the dermoepidermal junction and responds to topical agents. It looks brown, has a relatively soft edge, and lightens with retinoids, azelaic acid, or hydroquinone. Dermal hyperpigmentation sits in the mid-dermis, appears gray or blue-gray, has sharper borders, and resists topicals because the pigment is beyond the reach of most topical penetration.
Wood's lamp examination separates the two in clinic. Epidermal pigment enhances under Wood's lamp; dermal pigment does not and may appear slightly duller. This distinction changes both the prognosis and the treatment. Epidermal PIH can resolve in 8 to 12 weeks; dermal PIH often takes 6 to 12 months and may need low-fluence Q-switched 1064 nm "toning" sessions spaced 2 to 4 weeks apart.
The non-obvious caveat here is that treating PIH with more laser can worsen it. A second aggressive pass over an already inflamed area doubles the inflammatory load and can convert a superficial patch into a dermal one. Clinicians who specialize in darker skin increasingly favor conservative settings and longer intervals over rapid clearing.
Common Myths and a Corrected Misconception
Several beliefs about laser and pigmentation are wrong in ways that change behavior.
The first myth is that laser "melts" pigment immediately. In reality, most pigment clearance is immune-mediated and takes 4 to 8 weeks; the immediate darkening after Q-switched treatment is oxidized pigment, not clearance.
The second myth is that darker skin cannot be lasered at all. It can, but the safe window narrows: lower fluence, longer pulse duration, aggressive epidermal cooling, and test spots on hidden areas. The American Society for Laser Medicine and Surgery has published consensus guidance recommending test spots and conservative parameters for Fitzpatrick IV to VI skin.
The third and most counterintuitive correction: sunscreen alone does not prevent laser-induced PIH. Ultraviolet exposure worsens existing pigment, but the initial trigger is thermal, so photoprotection is a maintenance tool, not a primary preventive. Pre-treatment with topical retinoids or hydroquinone for 2 to 4 weeks can reduce risk, but not eliminate it.
What to Actually Do Before and After a Laser Session
Risk reduction is mostly logistical. The following actions are supported by dermatologic consensus rather than single trials.
- Confirm Fitzpatrick type and do a test spot on a hidden area at least 2 weeks before treating the face or hands.
- Stop retinoids, glycolic acid, and any exfoliant 5 to 7 days before treatment; resume only after redness clears.
- Ask for aggressive contact cooling and a lower fluence if you have type IV or darker skin.
- Use broad-spectrum SPF 50 daily for 8 weeks after treatment, reapplying every 3 hours outdoors.
- Avoid heat exposure such as saunas, hot yoga, and prolonged sun for 72 hours post-session.
- Photograph the area at baseline and at weeks 2, 4, and 8 so change is measured, not remembered.
The post-treatment window matters most. Starting a topical antioxidant or azelaic acid at week 2, once the skin barrier is intact, can blunt tyrosinase activity during the peak risk period. Starting it earlier irritates the skin and raises risk.
Red Flags That Require a Clinician
Most post-laser pigment is benign and self-limited. Some signs warrant prompt review.
- Blistering or open wounds that persist beyond 3 days.
- A patch that continues to darken beyond 8 weeks rather than stabilizing.
- Sharp, spreading borders or a change in texture, which can mimic other pigmentary disorders.
- Fever, spreading redness, or pus at the treated site.
- New pigment in an area that was not treated, suggesting a systemic or photosensitive trigger.
These do not prove a serious problem, but they shift the differential away from simple PIH and toward infection, scarring, or an unrelated pigmentary condition that needs different care.
Limitations of the Evidence and When Laser Is the Wrong Tool
The evidence base for laser-induced hyperpigmentation is uneven. Most published incidence figures come from single-center retrospective reviews, and device settings vary widely, so the 2% to 18% range reflects real heterogeneity rather than a single precise rate. Direct head-to-head trials comparing lasers for PIH risk are scarce, and most safety data for darker skin comes from small cohorts rather than randomized trials.
Laser is also the wrong tool in several situations. Active melasma responds poorly to laser and often rebounds; sun-damaged skin with diffuse lentigines may do better with topical or light-based therapy first. Patients with a history of keloids or recent isotretinoin use within 6 months need individualized assessment. Pregnancy and active infection at the site are relative contraindications.
The threshold sentence that ties the numbers together: risk rises progressively above Fitzpatrick type III, crosses roughly 15% at type IV and 30% at type V for pigment-specific devices, and falls back to single digits only when fluence, cooling, and interval are all adjusted downward. In other words, the laser is rarely the sole cause; the parameters and the skin type together determine whether hyperpigmentation happens. A measured, tested, and conservatively dosed approach keeps the risk near the low end of every range in this article.